Vitamin E supplementation and cardiovascular events in high-risk patients.

BACKGROUND Observational and experimental studies suggest that the amount of vitamin E ingested in food and in supplements is associated with a lower risk of coronary heart disease and atherosclerosis. METHODS We enrolled a total of 2545 women and 6996 men 55 years of age or older who were at high risk for cardiovascular events because they had cardiovascular disease or diabetes in addition to one other risk factor. These patients were randomly assigned according to a two-by-two factorial design to receive either 400 IU of vitamin E daily from natural sources or matching placebo and either an angiotensin-converting-enzyme inhibitor (ramipril) or matching placebo for a mean of 4.5 years (the results of the comparison of ramipril and placebo are reported in a companion article). The primary outcome was a composite of myocardial infarction, stroke, and death from cardiovascular causes. The secondary outcomes included unstable angina, congestive heart failure, revascularization or amputation, death from any cause, complications of diabetes, and cancer. RESULTS A total of 772 of the 4761 patients assigned to vitamin E (16.2 percent) and 739 of the 4780 assigned to placebo (15.5 percent) had a primary outcome event (relative risk, 1.05; 95 percent confidence interval, 0.95 to 1.16; P=0.33). There were no significant differences in the numbers of deaths from cardiovascular causes (342 of those assigned to vitamin E vs. 328 of those assigned to placebo; relative risk, 1.05; 95 percent confidence interval, 0.90 to 1.22), myocardial infarction (532 vs. 524; relative risk, 1.02; 95 percent confidence interval, 0.90 to 1.15), or stroke (209 vs. 180; relative risk, 1.17; 95 percent confidence interval, 0.95 to 1.42). There were also no significant differences in the incidence of secondary cardiovascular outcomes or in death from any cause. There were no significant adverse effects of vitamin E. CONCLUSIONS In patients at high risk for cardiovascular events, treatment with vitamin E for a mean of 4.5 years had no apparent effect on cardiovascular outcomes.

[1]  C. Rosow,et al.  Bispectral index monitoring , 2001 .

[2]  K. Oktay,et al.  Transplantation of cryopreserved human ovarian tissue results in follicle growth initiation in SCID mice. , 2000, Fertility and sterility.

[3]  R. Wilkinson,et al.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study , 2000, The Lancet.

[4]  R. Truog,et al.  Pharmacologic paralysis and withdrawal of mechanical ventilation at the end of life. , 2000, The New England journal of medicine.

[5]  R. Gosden,et al.  Ovary and ovulation: Low temperature storage and grafting of human ovarian tissue , 1996 .

[6]  L. Miller.  Caring for internationally adopted children. , 1999, The New England journal of medicine.

[7]  I. Onorato,et al.  Extensive transmission of Mycobacterium tuberculosis from a child. , 1999, The New England journal of medicine.

[8]  G. Fraser,et al.  Assessing sedation during intensive care unit mechanical ventilation with the Bispectral Index and the Sedation-Agitation Scale. , 1999, Critical care medicine.

[9]  R. Stocker,et al.  Tocopherol‐mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  C. Di Mario,et al.  Treatment of a coronary aneurysm with a new polytetrafluoethylene‐coated stent: A case report , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[11]  A. Hofman,et al.  Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. , 1999, The American journal of clinical nutrition.

[12]  M. Campbell,et al.  Patient responses during rapid terminal weaning from mechanical ventilation: a prospective study. , 1999, Critical care medicine.

[13]  D. Chadee,et al.  Re-emergence of Plasmodium malariae in Trinidad, West Indies. , 1999, Annals of tropical medicine and parasitology.

[14]  F. Alfonso,et al.  Coronary rupture during stent implantation. , 1998, Circulation.

[15]  K. Oktay,et al.  Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. , 1998, Human reproduction.

[16]  M. Traber,et al.  Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. , 1998, The American journal of clinical nutrition.

[17]  S. Ripatti,et al.  Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. , 1998, Archives of internal medicine.

[18]  J S Hammond,et al.  Patient Recall of Therapeutic Paralysis in a Surgical Critical Care Unit , 1998, Pharmacotherapy.

[19]  T. McCutchan,et al.  Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. , 1998, New England Journal of Medicine.

[20]  P. Galan,et al.  Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Minéraux AntioXydants Study. , 1998, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[21]  K. Oktay,et al.  Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology? , 1998, Fertility and sterility.

[22]  S. Ripatti,et al.  Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction , 1997, The Lancet.

[23]  A. Folsom,et al.  Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. , 1996, The New England journal of medicine.

[24]  S. Yusuf,et al.  Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE. , 1996, The American journal of cardiology.

[25]  M. Brown,et al.  A Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: The Cambridge Heart Antioxidant Study (CHAOS) , 1996 .

[26]  M. Steiner,et al.  Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. , 1995, The American journal of clinical nutrition.

[27]  S. Yusuf,et al.  The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial Data , 1995, Annals of Internal Medicine.

[28]  G. Dorros,et al.  Management of coronary artery rupture: covered stent or microcoil embolization. , 1995, Catheterization and cardiovascular diagnosis.

[29]  D. Steinberg.  Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? , 1995, The Lancet.

[30]  G A Colditz,et al.  A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. , 1995, Annals of epidemiology.

[31]  S. Azen,et al.  Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. , 1995, JAMA.

[32]  D. Kwiatkowski,et al.  Malarial toxins and the regulation of parasite density. , 1995, Parasitology today.

[33]  M. Kendall,et al.  The oxidation hypothesis of atherosclerosis , 1994, The Lancet.

[34]  A. Reunanen,et al.  Antioxidant vitamin intake and coronary mortality in a longitudinal population study. , 1994, American journal of epidemiology.

[35]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[36]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[37]  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[38]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[39]  P. Gallagher,et al.  Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. , 1992, Atherosclerosis.

[40]  Verlangieri Aj,et al.  Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. , 1992 .

[41]  R. Douglas,et al.  Plasmodium species (malaria). , 1990 .

[42]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[43]  B. Milleron,et al.  Vitamin D metabolism in tuberculosis. Production of 1,25(OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. , 1988, The American review of respiratory disease.

[44]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Davies.  A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. , 1985, Tubercle.

[46]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[47]  S. Manolagas,et al.  1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. , 1984, Science.